4//SEC Filing
Sage Therapeutics, Inc. 4
Accession 0001562180-16-003622
CIK 0001597553operating
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:03 PM ET
Size
8.7 KB
Accession
0001562180-16-003622
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2016-11-15$8.92/sh+10,000$89,200→ 10,000 total - Sale
Common Stock
2016-11-15$55.00/sh−10,000$550,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-11-15−10,000→ 167,038 totalExercise: $8.92Exp: 2024-05-21→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2015 Stock Option and Incentive Plan. The option shall vest in full on May 5, 2018, subject to continued service through such date.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597553
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 4:03 PM ET
- Size
- 8.7 KB